Thank You For Registering!

Thank you for registering.

You will shortly be receiving an automatic email confirming your online registration and within the next 24 hours, you will receive your invoice and/or payment confirmation.

If you have any questions about your registration, please contact

Telephone: +1 713 554 8380 or +1 (212) 537 5898

Email: customersupport@hansonwade.com

We look forward to welcoming you to the conference.

Want to Share That You Are Attending?

We would love for you to share that you are you attending the 5th Gamma Delta T Cell Therapies Summit. Please see your banner below.

Want to make it even easier? Here is some text to go with it: ''I am attending the 5th Gamma Delta T Cell Therapies Summit this July. I am looking forward to hearing from industry experts delve into the details of gamma delta biology and its various subsets to offer the audience a well-rounded overview of the landscape currently and the steps needed for it to move forward. Join me! https://ter.li/gt5ipt

Continue Your Cell Therapy Journey

 

Cell Therapy


Delivering Safer, More Effective & Globally Accessible Cell Therapies to Patients at Scale

Conferences

Our Cell Therapy conferences aim to supercharge durable, safe, and cost-effective cell therapies for patients. We focus on helping overcome the discovery, translational, clinical, and commercial hurdles to realize cell therapies for patients at scale.

Data 

Beacon's cell therapy database covers trial and drug records for preclinical, active, approved, and discontinued CAR (chimeric antigen receptor) modified therapies, TCR (T-Cell Receptor) therapies, natural killer cells, tumor-infiltrating lymphocytes cytokine-induced killer cells, dendritic cells, and macrophages.

Networking

A year-round experience-sharing and problem-solving network helping drug developers address critical R&D challenges in CAR-TCR therapies for solid tumors. 

Research

A trusted provider of market intelligence for anyone looking to understand the complexities of cell therapy research and development.